Cowen Inc’s Quest Diagnostics DGX Stock Holding History

Cowen Inc’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,530	Closed	-$348K	–	478
2015 Q1	$348K	Buy	+4,530	New	+$324K	0.03%	254

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Cowen Inc's DGX Position: Q2 2015 in Review

Cowen Inc sold out of Quest Diagnostics (DGX) in Q2 2015, closing a stake of 4,530 shares — an estimated $348K sold.

Cowen Inc first reported a position in DGX in Q1 2015 and held it in 1 quarter. The position peaked at $348K in Q1 2015. 542 funds tracked by Wall St. Rank hold DGX as of Q2 2015.

Cowen Inc reported no remaining Quest Diagnostics position as of Q2 2015 after selling out during the quarter.
Cowen Inc sold 4,530 Quest Diagnostics shares in Q2 2015, an estimated $348K.
Cowen Inc first reported a position in Quest Diagnostics in Q1 2015 and held it in 1 quarter.
Cowen Inc's Quest Diagnostics position peaked at $348K in Q1 2015.
542 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2015.

Based on Cowen Inc's 13F filing for Q2 2015, filed 14 Aug 2015.